Hudson Technologies, Inc. (HDSN)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
$5.35+1.90%
Close 2026-09-04 · 1-day change
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
Intact: The reason to own it still holds.
Hudson grew revenue from $44 million to $60 million in Q1. They aim for $73-$76 million in Q2 2026. Management is buying shares, showing confidence. The company is expanding through acquisitions.
Hudson missed earnings twice recently. Key sales and board leaders left. Free cash flow is negative. Capital allocation is uncertain with credit facility changes.
The price is about 8% below our fair value near $7. Analysts expect 2% revenue growth. Our view sees risk in execution and cash flow.
Breaks if: Capital moves worsen financial risk or increase debt unsustainably
Breaks if: No material M&A activity in next 4 quarters
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a focus on operational excellence and strategic partnerships. The current thesis state is cautious, given recent earnings misses and mixed management priorities.
The market seems to have priced in a low level of execution quality, with a valuation described as cheap compared to peers. There is an expectations gap indicating that the market may not fully anticipate the potential for recovery or growth.
Fundamentals may improve if management successfully drives revenue growth and retains key government contracts. However, there is an elevated risk of further earnings misses, which could impact investor sentiment.
The thesis hinges on management's ability to raise guidance in the next quarter, the performance of sector bellwethers, and the potential reacceleration of inflation. These factors could significantly influence HDSN's trajectory in the coming months.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings miss negatively impacted the outlook for HDSN. This miss raises concerns about the company's ability to meet future expectations.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Revenue falls below $73 million in Q2 2026
Achieve revenue between $73 million and $76 million for the second quarter of 2026.
Over the next 1 to 3 years, HDSN's performance will depend on execution and external market conditions. Not investment advice.